Association between menopausal hormone therapy, mammographic density and breast cancer risk: results from the E3N cohort study.
M ForniliV PerducaA FournierA JérolonM C Boutron-RuaultG MaskarinecGianluca SeveriL BagliettoPublished in: Breast cancer research : BCR (2021)
Our results suggest that, under a causal model, nearly half of the effect of MHT on hormone receptor-positive BC risk is mediated by mammographic density, which appears to be modified by MHT for up to 8 years after MHT termination.